A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/1999
09/01/1999	EP0938315A1 Immune response modifier compounds for treatment of th2 mediated and related diseases
09/01/1999	EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor
09/01/1999	EP0723455A4 Methods of inhibiting phagocytosis
09/01/1999	EP0700301B1 Peptides and compounds that bind to elam-1
09/01/1999	EP0573545B1 Monoclonal antibodies against receptor-induced binding sites
09/01/1999	CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
09/01/1999	CN1227554A Substituted 6,5-hetero-bicyclic derivatives
09/01/1999	CN1227547A Arylalkanoyl pyridazines
09/01/1999	CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect
09/01/1999	CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
09/01/1999	CN1227501A Long-acting drugs and pharmaceutical compositions comprising them
09/01/1999	CN1227120A Preparation for senile disease
09/01/1999	CN1227115A Anti-senility kindney invigorating health medicine and its preparing method
09/01/1999	CN1044906C 3(2H)-pyridazinono derivatives, its preparing method and its composition
08/1999
08/31/1999	US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents
08/31/1999	US5945508 Administering aerosolized mutant substance p as antimetastasis agent
08/31/1999	US5945440 Indolocarbazole imides and the use thereof
08/31/1999	US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
08/31/1999	US5945401 Polypeptides as antidiabetic agents
08/31/1999	US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent
08/31/1999	US5945310 DNA encoding members of the IL-1 family, IL-1 delta
08/31/1999	US5945308 Polynucleotide
08/31/1999	US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases
08/31/1999	US5945105 Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE)
08/31/1999	US5945104 A peptide carrier conjugate where carrier is selected from tetanus-texoid and purified protein derivative of tuberculin
08/31/1999	US5945102 Crustacean and fish derived multifunctional enzyme
08/31/1999	CA2145835C Hydroxamic acid derivatives with tricyclic substitution
08/26/1999	WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR
08/26/1999	WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
08/26/1999	WO1999042584A1 Apoptosis inducing molecule ii and methods of use
08/26/1999	WO1999042562A1 NOVEL pgsA
08/26/1999	WO1999042485A1 Mucilage, a g-protein-coupled receptor
08/26/1999	WO1999042446A1 Cyclic amide compounds
08/26/1999	WO1999042133A1 Inhibitors of complement activation
08/26/1999	WO1999042124A1 Liquid crystal forms of cyclosporin
08/26/1999	WO1999042105A1 Epimorphian compound and its use
08/26/1999	WO1999042101A1 Dietary control of arachidonic acid metabolism
08/26/1999	WO1999042077A2 Compositions and methods for regulating lymphocyte activation
08/26/1999	WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999	WO1999042075A2 Antibodies against human cd40
08/26/1999	WO1999033989A3 Rantes mutants and therapeutic applications thereof
08/26/1999	WO1999031060A3 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants
08/26/1999	WO1999029883A3 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease
08/26/1999	WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
08/26/1999	WO1999027954A3 Mixed lipopeptide micelles for inducing an immune response
08/26/1999	WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/26/1999	WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
08/26/1999	WO1998030696A8 Secreted proteins and polynucleotides encoding them
08/26/1999	WO1998004693A3 Secreted proteins and polynucleotides encoding them
08/26/1999	DE19811326C1 Preparation of medicaments for the treatment of tumor diseases and for immuno-suppression
08/26/1999	CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects
08/26/1999	CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/26/1999	CA2321199A1 Compositions and methods for regulating lymphocyte activation
08/26/1999	CA2321186A1 Apoptosis inducing molecule ii and methods of use
08/26/1999	CA2321165A1 Antibodies against human cd40
08/26/1999	CA2321140A1 Inhibitors of complement activation
08/26/1999	CA2320971A1 Cyclic amide compounds
08/26/1999	CA2318959A1 Epimorphian compound and its use
08/25/1999	EP0937777A2 GABA receptors and their uses
08/25/1999	EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
08/25/1999	EP0937144A1 Human eosinophil-derived basic protein
08/25/1999	EP0937143A2 Secreted proteins and polynucleotides encoding them
08/25/1999	EP0937141A1 Polynucleotides encoding secreted proteins from human dendritic cells
08/25/1999	EP0937103A2 Compounds and methods for modulating cell adhesion
08/25/1999	EP0937102A1 Human monocyte chemotactic proprotein
08/25/1999	EP0937089A1 New knoevenagel condensation products, method for their production and their use
08/25/1999	EP0937069A1 Piperazino derivatives as neurokinin antagonists
08/25/1999	EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
08/25/1999	EP0937038A1 Vitamin d analogues
08/25/1999	EP0646016B1 Synthetic peptides for the treatment of myasthenia gravis
08/25/1999	EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
08/25/1999	CN1226899A Synthetic IL-10 analogues
08/25/1999	CN1226897A Isolated peptides derived from mage-2
08/25/1999	CN1226426A Hanjingbaoyuan beverage
08/24/1999	US5942605 Antitumor agents synthesized from anthracycline 13-tosylhydrazone; side effect reduction
08/24/1999	US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof
08/24/1999	US5942521 Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient
08/24/1999	US5942507 Furan nitrone compounds
08/24/1999	US5942504 Amine derivatives of oxo- and hydroxy- substituted hydrocarbons
08/24/1999	US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides
08/24/1999	US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation
08/24/1999	US5942253 Prolonged release of GM-CSF
08/24/1999	US5942237 Pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
08/24/1999	US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy
08/24/1999	US5942231 Daily bathing in a bathtub with a water-permeable bag containing the dry powder of guava leaves; treatment of allergic diseases
08/24/1999	US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent
08/24/1999	CA2147126C Piperidine derivatives and process for their production
08/20/1999	CA2249653A1 Novel compounds
08/19/1999	WO1999041402A2 Targeting of genetic vaccine vectors
08/19/1999	WO1999041375A2 Human receptor proteins
08/19/1999	WO1999041374A2 Human short-chain tnf-receptor family protein
08/19/1999	WO1999041369A2 Genetic vaccine vector engineering
08/19/1999	WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines
08/19/1999	WO1999041355A2 Hiv chemokines
08/19/1999	WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG
08/19/1999	WO1999041264A1 Methods of synthesizing gm3
08/19/1999	WO1999041257A1 Glucocorticoid-selective antiinflammatory agents
08/19/1999	WO1999041252A1 Antagonists of gonadotropin releasing hormone
08/19/1999	WO1999041247A1 TREATMENT OF MULTIPLE SCLEROSIS USING COP-1 AND Th2-ENHANCING CYTOKINES
08/19/1999	WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors

1 ... 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 ... 1172